Beta Bionics reports real-world iLet data: HbA1c drops from 8.9% to 7.3% in 14,952 users

Beta Bionics, Inc.

16,439 iLet users uploaded data in first 2 years; 14,952 with baseline HbA1c showed avg drop from 8.9% to 7.3% GMI.
8,802 prior MDI users improved from 9.2% to 7.3%; 2,910 prior HCL users improved from 8.1% to 7.3%.
2,416 'fully-closed loop' users (≤1 meal announcement/day) improved from 9.4% to 7.5% GMI; 83% met ADA hypoglycemia goals.
Adaptive algorithm reaches steady state in ~2 days; similar outcomes seen in primary care and endocrinology practices.
Company highlights pharmacy channel strategy and bionic portal for HCPs; no financial guidance provided.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.